Summary

Dr. Massimo Gadina is the Director of the Office of Science and Technology (OST) at the NIAMS, supporting intramural researchers with core technologies. He also serves as Chief of the Translational Immunology Section of the OST. Prior to this appointment, he was Senior Lecturer at the Division of Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, The Queen's University of Belfast, Northern Ireland.

Research Statement

Dr. Gadina's research interests are focused on immune-mediated diseases and specifically, the biology of cytokines and their relative signaling pathways. His translational work is also focused on autoinflammatory diseases and other inflammatory diseases.

Education

Università di Milano, Italy
Doctor of Pharmaceutical Chemistry and Technology

Université de Bourgogne, Dijon, France
Diplôme de Docteur

Experience

Director, Office of Science and Technology
Chief, Translational Immunology Section
NIAMS, NIH, 2009 - present

    
Staff Scientist, Acting Director, Office of Science and Technology
Acting Chief Translational Immunology Section
NIAMS, NIH, 2008 - 2009

Senior Lecturer, Tenured
Division of Infection and Immunity, School of Medicine Dentistry and Biomedical Sciences, The Queen’s University of Belfast, Northern Ireland, U.K., 2003 - 2008

Staff Scientist
Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, NIAMS, NIH, 2000 - 2002

Visiting Associate
Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, NIAMS, NIH, 1996 - 1999

Research Associate-Staff Scientist
Division of Experimental Oncology E, Istituto Nazionale per lo Studio e la Cura dei Tumori,Milano, Italy, 1990 - 1996.

Last Reviewed: 03/23/2017